EURETINA Educational Debate Webinar
Double Debate chaired by Ramin Tadayoni (FRANCE) & Anat Loewenstein (ISRAEL)
Price: Free
Date: Thursday 11th January 2024
Time: 20:00 CET / 19:00 GMT
Where: Virtual (link provided)
Hosted by
Ramin Tadayoni
FRANCE
Anat Loewenstein
ISRAEL
Debates
1. Pegcetacoplan: Are Monthly Injections of Pegcetacoplan Worthwhile for Reducing Fry AMD Progression by 20%?
Join Jordi Mones (SPAIN) & Michaella Goldstein (ISRAEL) as they debate ‘Pegcetacoplan: Are Monthly Injections of Pegcetacoplan Worthwhile for Reducing Fry AMD Progression by 20%’.
Jordi Mones
SPAIN
Michaella Goldstein
ISRAEL
2. Long-Acting Anti-VEGF Agents on the Horizon: is Monitoring Between Injections Needed?
Join Anat Loewenstein (ISRAEL) & Gemmy Cheung (SINGAPORE) as they debate ‘Long-Acting Anti-VEGF Agents on the Horizon: is Monitoring Between Injections Needed?’.
Anat Loewenstein
ISRAEL
Gemmy Cheung
SINGAPORE
Schedule
Welcome and introduction
Ramin Tadayoni (FRANCE) & Anat Loewenstein (ISRAEL)
First Debate: Pegcetacoplan: Are Monthly Injections of Pegcetacoplan Worthwhile for Reducing Fry AMD Progression by 20%?
Jordi Mones (SPAIN) & Michaella Goldstein (ISRAEL)
In favour of the motion
Jordi Mones (SPAIN)
Against the motion
Michaella Goldstein (ISRAEL)
Second Debate: Long-Acting Anti-VEGF Agents on the Horizon: is Monitoring Between Injections Needed?
Anat Loewenstein (ISRAEL) & Gemmy Cheung (SINGAPORE)
In favour of the motion
Anat Loewenstein (ISRAEL)
Against the motion
Gemmy Cheung (SINGAPORE)
Closing remarks
Ramin Tadayoni (FRANCE) & Anat Loewenstein (ISRAEL)
Double Debate
In case you missed it, the previous Double Debate with Alistair Laidlaw and Anat Loewenstein is available online.
Catch up on this 60-minute Double Debate chaired by Alistair Laidlaw (UK) and Anat Loewenstein (ISRAEL).
Recording only available to Members.
Recording only available to Members.
Browse all digital events here.
